Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data.

scientific article

Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1055/A-0603-4350
P932PMC publication ID5986564
P698PubMed publication ID29880983

P50authorAndré ReisQ522465
Matthias W. BeckmannQ72940290
Arndt HartmannQ89782316
Michael P. LuxQ37372079
Peter A. FaschingQ64005064
Arif B. EkiciQ64409983
P2093author name stringAlexander Hein
Claudia Rauh
Rüdiger Schulz-Wendtland
Sebastian M Jud
Cornelia Kraus
Juliane Hoyer
Lothar Häberle
Naiba Nabieva
Ramona Erber
Georgia Vasileiou
Carolin C Hack
Marius Wunderle
Gregor Olmes
P2860cites workComparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluationsQ78299914
Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patientsQ80122576
Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer ConsortiQ86554647
Initial clinical results with a fusion prototype for mammography and three-dimensional ultrasound with a standard mammography system and a standard ultrasound probeQ87935958
Genome-wide association studies identify four ER negative-specific breast cancer risk lociQ24622610
Comprehensive molecular portraits of human breast tumoursQ24630844
Genome-wide association study identifies novel breast cancer susceptibility lociQ24645441
Recent Enhancements to the Genetic Risk Prediction Model BRCAPROQ26995389
Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort studyQ28075560
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancerQ28303909
Large-scale genotyping identifies 41 new loci associated with breast cancer riskQ29416989
Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.Q30238753
Determination of interval cancer rates in the German mammography screening program using population-based cancer registry dataQ30719843
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerQ33566957
CYP2D6 polymorphisms as predictors of outcome in breast cancer patients treated with tamoxifen: expanded polymorphism coverage improves risk stratificationQ33591915
Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survivalQ33828680
Breast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese populationQ33892384
Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactionsQ34038964
Performance of common genetic variants in breast-cancer risk modelsQ34064069
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).Q34085748
Genome-wide association study identifies five new breast cancer susceptibility lociQ34114293
Assessment of clinical validity of a breast cancer risk model combining genetic and clinical informationQ34267477
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2Q34384153
Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancerQ34631785
Combined associations of genetic and environmental risk factors: implications for prevention of breast cancerQ34736112
Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test resultsQ34788325
Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factorsQ34898735
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancerQ34996647
Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifenQ35006860
Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer riskQ35061252
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general populationQ35089479
Model for individualized prediction of breast cancer risk after a benign breast biopsyQ35144259
Lifetime cancer risks in individuals with germline PTEN mutations.Q35681689
Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density MeasuresQ35752042
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancerQ35755874
The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patientsQ35781316
Common germline polymorphisms associated with breast cancer-specific survivalQ35794653
19p13.1 is a triple-negative-specific breast cancer susceptibility locusQ35871567
A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic densityQ35957063
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancerQ35996692
Identification of novel genetic markers of breast cancer survivalQ36014067
The contributions of breast density and common genetic variation to breast cancer riskQ36137764
The role of genetic breast cancer susceptibility variants as prognostic factorsQ36142060
Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohortQ36336239
Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurementQ36393193
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.Q36435849
The incidence of interval cancers in the German mammography screening program: results from the population-based cancer registry in North Rhine-WestphaliaQ36446560
SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survivalQ36545934
Prediction of breast cancer risk based on profiling with common genetic variantsQ36583004
Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer riskQ36600605
Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trialQ36634556
iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and managementQ36678510
The BOADICEA model of genetic susceptibility to breast and ovarian cancerQ36695832
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factorsQ36720821
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancersQ36742577
Genome-wide association analysis identifies three new breast cancer susceptibility lociQ36842233
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancerQ36897003
Comparison of Clinical and Automated Breast Density Measurements: Implications for Risk Prediction and Supplemental ScreeningQ36950678
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive modelQ37172219
Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.Q37300024
Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association ConsortiumQ37307937
Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and OlderQ37353842
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.Q37356243
Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.Q37369631
Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk modelQ37378034
Mammography Screening - as of 2013.Q37389694
BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interfaceQ37507410
CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populationsQ37524058
The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common CancersQ37578078
High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendationsQ37669153
A clinical model for identifying the short-term risk of breast cancerQ37697979
Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomesQ38613552
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation CarriersQ38717239
Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association studyQ39006292
Mammographic density is the main correlate of tumors detected on ultrasound but not on mammographyQ39622978
Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancerQ39958494
Gene-environment interactions involving functional variants: Results from the Breast Cancer Association ConsortiumQ40137431
A Standard Mammography Unit - Standard 3D Ultrasound Probe Fusion Prototype: First ResultsQ40486932
Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection MethodsQ41011976
Using automated texture features to determine the probability for masking of a tumor on mammography, but not ultrasoundQ41570633
Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and BeyondQ41579926
Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patientsQ42013702
Clinical validation of genetic variants associated with in vitro chemotherapy-related lymphoblastoid cell toxicityQ45746480
Association analysis identifies 65 new breast cancer risk loci.Q45979098
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancerQ46103372
Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto studyQ46721561
Associations Between Cancer Predisposition Testing Panel Genes and Breast CancerQ46782579
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association ConsortiumQ47190168
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort studyQ47552886
Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials.Q48717652
Breast cancer in young women: do BRCA1 or BRCA2 mutations matter?Q50033721
Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer.Q51764547
A breast cancer prediction model incorporating familial and personal risk factors.Q52000310
[Future of mammography-based imaging].Q53077783
A common coding variant in CASP8 is associated with breast cancer riskQ57250674
Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancerQ57251792
The calculation of breast cancer risk for women with a first degree family history of ovarian cancerQ72397549
Validation studies on a model for breast cancer riskQ72412463
P433issue5
P304page(s)481-492
P577publication date2018-05-01
P1433published inGeburtshilfe und Frauenheilkunde: Ergebnisse der Forschung für die PraxisQ26841999
P1476titleRisk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data.
P478volume78

Reverse relations

cites work (P2860)
Q90107270Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy
Q90285490Diagnostic Accuracy of Breast Medical Tactile Examiners (MTEs): A Prospective Pilot Study
Q92103705Epithelial ovarian cancer risk: A review of the current genetic landscape
Q90219103Mexican BRCA1 founder mutation: Shortening the gap in genetic assessment for hereditary breast and ovarian cancer patients
Q90547034RANKL and OPG and their influence on breast volume changes during pregnancy in healthy women
Q98514326Supervariants identification for breast cancer
Q59335358Update Breast Cancer 2018 (Part 3) – Genomics, Individualized Medicine and Immune Therapies – in the Middle of a New Era: Prevention and Treatment Strategies for Early Breast Cancer
Q59335362Update Breast Cancer 2018 (Part 4) – Genomics, Individualized Medicine and Immune Therapies – in the Middle of a New Era: Treatment Strategies for Advanced Breast Cancer
Q64102998Update Breast Cancer 2019 Part 1 - Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer
Q64102991Update Breast Cancer 2019 Part 2 – Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice
Q90092211Update Breast Cancer 2020 Part 1 - Early Breast Cancer: Consolidation of Knowledge About Known Therapies
Q58587476[TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes]

Search more.